RATIONALE: A growing number of infants are being exposed to selective serotonin reuptake inhibitor (SSRI) medications during the perinatal period. SSRIs target the serotoninergic system and are a popular treatment for maternal mood disorders. Serotonin itself plays a key role in the sexual differentiation through its role in the development of the hypothalamic-pituitary-gonadal axis, and previous research has shown that developmental SSRI exposure has an effect on sexual behavior in male offspring. OBJECTIVES: Our aim was to determine the role of developmental exposure to a popular SSRI medication, fluoxetine, on sexual differentiation of the brain and behavior in female offspring using a rodent model of maternal adversity. METHODS: Stressed and non-stressed Sprague-Dawley rat dams were chronically treated with either fluoxetine (5 mg/kg/day) or vehicle beginning on postnatal day 1. Four groups of female offspring were used: (1) control + vehicle, (2) control + fluoxetine, (3) prenatal stress + vehicle, and (4) prenatal stress + fluoxetine. RESULTS: Primary results show that in adult female offspring, developmental fluoxetine exposure facilitates proceptive and receptive behaviors with a significant increase in the number of proceptive behaviors, a significant increase in the lordosis quotient, and a significant decrease in the rejection quotient. CONCLUSIONS: This research contributes in the understanding of the long-term impact developmental fluoxetine exposure on the hypothalamus-pituitary-gonadal (HPG) system in adult female offspring.
RATIONALE: A growing number of infants are being exposed to selective serotonin reuptake inhibitor (SSRI) medications during the perinatal period. SSRIs target the serotoninergic system and are a popular treatment for maternal mood disorders. Serotonin itself plays a key role in the sexual differentiation through its role in the development of the hypothalamic-pituitary-gonadal axis, and previous research has shown that developmental SSRI exposure has an effect on sexual behavior in male offspring. OBJECTIVES: Our aim was to determine the role of developmental exposure to a popular SSRI medication, fluoxetine, on sexual differentiation of the brain and behavior in female offspring using a rodent model of maternal adversity. METHODS: Stressed and non-stressed Sprague-Dawley rat dams were chronically treated with either fluoxetine (5 mg/kg/day) or vehicle beginning on postnatal day 1. Four groups of female offspring were used: (1) control + vehicle, (2) control + fluoxetine, (3) prenatal stress + vehicle, and (4) prenatal stress + fluoxetine. RESULTS: Primary results show that in adult female offspring, developmental fluoxetine exposure facilitates proceptive and receptive behaviors with a significant increase in the number of proceptive behaviors, a significant increase in the lordosis quotient, and a significant decrease in the rejection quotient. CONCLUSIONS: This research contributes in the understanding of the long-term impact developmental fluoxetine exposure on the hypothalamus-pituitary-gonadal (HPG) system in adult female offspring.
Authors: J L Pawluski; I Rayen; N A Niessen; S Kristensen; E L van Donkelaar; J Balthazart; H W Steinbusch; T D Charlier Journal: Neuroscience Date: 2012-06-21 Impact factor: 3.590
Authors: Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul Journal: Neuropsychopharmacology Date: 2006-01 Impact factor: 7.853
Authors: Kim M Gerecke; Rehka Kishore; Aaron Jasnow; Princy Quadros-Menella; Susan Parker; Frederick J Kozub; Kelly G Lambert; Craig Howard Kinsley Journal: Dev Psychobiol Date: 2011-06-08 Impact factor: 3.038
Authors: Shuk-Mei Ho; Ana Cheong; Margaret A Adgent; Jennifer Veevers; Alisa A Suen; Neville N C Tam; Yuet-Kin Leung; Wendy N Jefferson; Carmen J Williams Journal: Reprod Toxicol Date: 2016-07-12 Impact factor: 3.143
Authors: Ine Rayen; Mary Gemmel; Grace Pauley; Harry W M Steinbusch; Jodi L Pawluski Journal: Psychopharmacology (Berl) Date: 2014-10-12 Impact factor: 4.530
Authors: Aarthi R Gobinath; Joanna L Workman; Carmen Chow; Stephanie E Lieblich; Liisa A M Galea Journal: Biol Sex Differ Date: 2017-06-02 Impact factor: 5.027
Authors: Danielle J Houwing; Diana C Esquivel-Franco; Anouschka S Ramsteijn; Kirsten Schuttel; Eline L Struik; Chantal Arling; Sietse F de Boer; Jocelien D A Olivier Journal: Psychopharmacology (Berl) Date: 2020-07-17 Impact factor: 4.530